5+ day, 12+ hour ago   (229+ words) Clinical Leader Beyond A Single Disease: Traversing Complexity In Breast Cancer Clinical Development The science of breast cancer treatment is moving faster than many trial teams can operationally keep pace with. Precision medicine, biomarker-defined patient populations, novel therapeutic modalities, and…...

1+ week, 6+ day ago   (401+ words) Guest Column | September 1, 2026 A conversation between Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC) Director Caitlyn Barrett, Ph.D., and Clinical Leader Executive Editor Abby Proch It’s been three years since an anonymous donor gave $96 million to Children’s National…...

2+ week, 4+ day ago   (613+ words) Guest Column | August 27, 2026 By David Adler, MD, Ph.D., MBA It may sound like an unlikely way to arrive at a career in oncology, but one of the earliest reasons I became interested in cancer was a child in my neighborhood…...

2+ week, 6+ day ago   (618+ words) Guest Column | August 25, 2026 A conversation between Oncolytics Biotech Scientific Advisor Richard Vile, Ph.D., and Clinical Leader Executive Editor Abby Proch Clinical Leader: For those of us who don't specialize in immunology, can you give us a primer, so to speak,…...

2+ week, 6+ day ago   (146+ words) Clinical Leader Turning Patient Advocacy Into Meaningful Trial Engagement Building meaningful relationships with patient advocacy organizations (PAOs) is a critical step in advancing rare disease research, particularly for sponsors entering an unfamiliar therapeutic area. This case study explores how a…...

3+ week, 4+ hour ago   (603+ words) Guest Column | August 24, 2026 A conversation between BriaCell President and CEO William Williams, MD, FACP, and Clinical Leader Executive Editor Abby Proch Developing a last-line cancer treatment is a complex space to occupy — as stressful and high stakes as it is…...

3+ week, 4+ hour ago   (370+ words) Guest Column | August 24, 2026 By Partha Anbil and Deepak Manjrekar A primary challenge in clinical research has always been patient recruitment and enrollment. Historically, identifying eligible patients, particularly for complex trials with stringent inclusion and exclusion criteria, required manual chart reviews…...

3+ week, 3+ day ago   (392+ words) Guest Column | August 21, 2026 A conversation between Boehringer Ingelheim Head Of U.S. Clinical Development Operations Karen Correa, Ph.D., and Clinical Leader Executive Editor Abby Proch If you’re looking for community engagement to be the salve for lagging patient enrollment, you’re already too…...